2.490USD+2.05%Mkt Cap: 7.69M USDP/E: —Last update: 2026-05-22
Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worl…
Industry Peers
Medical Devices152.25BUSDP/E 24.5
85.88BUSDP/E 24.2
53.45BSEKP/E 22.7
53.33BSEKP/E 98.9
52.13BDKKP/E 22.1
38.61BEURP/E 18.3
23.15BSEK—
22.25BEURP/E 23.4
loading…
Indicators:|
Key Statistics
Company
Market Cap7.69M USD
Enterprise Value6.40M USD
Revenue (TTM)4.33M USD
Gross Profit498.00K USD
Net Income (TTM)-4.97M USD
Revenue/Share1.608 USD
Last Price2.490 USD
Fiscal Year EndMay 2025
MR QuarterFeb 2026
Employees53
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)6.26
PEG—
EV/EBITDA-1.21
EV/Revenue1.48
P/S1.74
P/B2.23
EPS (TTM)-1.61
EPS (Forward)0.39
52W Range
1.87023% of range4.600
52W High4.600 USD
52W Low1.870 USD
Profitability
Gross Margin9.38%
Oper. Margin-131.51%
EBITDA Margin-121.75%
Profit Margin-93.64%
ROE-121.14%
ROA-83.65%
Growth
Revenue Growth-11.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.84M USD
CapEx (TTM)37.00K USD
FCF Margin-46.88%
FCF Yield-26.36%
Net Debt-1.14M USD
Net Debt/EBITDA0.22
Balance Sheet
Debt/Equity0.11
Current Ratio2.64
Quick Ratio1.46
Book Value/Sh1.095 USD
Cash/Share0.4320 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:8
Split DateApr 21, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.3.09M
Float2.77M
Insiders15.24%
Institutions3.62%
Short Interest
Short Ratio4.2d
Short % Float2.31%
Short % Out.2.05%
Shares Short63.38K
Short (prev mo.)73.53K
Technical
SMA 502.174 (+14.6%)
SMA 2002.518 (-1.1%)
Beta0.28
S&P 52W Chg28.31%
Avg Vol (30d)17.93K
Avg Vol (10d)20.42K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—